Document is current

Any future updates will be listed below

Population pharmacokinetic modeling of idelalisib, a novel PI3Kδ inhibitor, in healthy subjects and patients with hematologic malignancies

Crossref DOI link: https://doi.org/10.1007/s00280-015-2891-8

Published Online: 2015-12-08

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark